Adaptimmune Therapeutics plc (ADAP) declined -6.05% or -0.23 to $3.57. It is approximately 211755 shares traded, which is 54.3% compare to the average total volume 389979. The market cap of ADAP is $373.87 million. The year to date change is -37.46%. The 52 week price range is from $3.2 to $14.54. Price of ADAP have changed 11.76% during last week. It have changed -13.04% over last month, -13.44% over last 3 months, -33.91% over last 6 months and -69.82% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 4.20. It is 17.65% above current price. The 200-day Moving Averages for ADAP is 6.38. It is 78.71% above current price. The 52-week High is 14.54. It is 307.28% from the current price. The 52-week Low is 3.2. It is -10.36% from current price.
There are some statistics of ADAP. It is has market cap $373.87 million. The share outstanding is 104.73 million. The average volume is 389979. The percent of top 15 Institution holding is 74.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -51.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -41.11%.